Arterial thoracic outlet syndrome

Summary

Arterial thoracic outlet syndrome (MONDO:0018164) is a disease. A subtype of thoracic outlet syndrome — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	arterial thoracic outlet syndrome
Mondo ID	MONDO:0018164
Orphanet	357107
SNOMED CT	8051000119105
UMLS	C1956395
MedGen	365116
GARD	0021535
Is cancer (heuristic)	no

Also known as: arterial cervical rib syndrome · arterial costoclavicular syndrome · arterial hyperabduction syndrome · arterial scalenus anticus syndrome · arterial thoracic outlet compression syndrome · arterial TOS · ATOS

Disease family

This is a subtype of thoracic outlet syndrome. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › syndromic disease › thoracic outlet syndrome › arterial thoracic outlet syndrome

Related subtypes (2): neurogenic thoracic outlet syndrome, venous thoracic outlet syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.